These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23768206)

  • 41. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
    Chauhan BF; Chartrand C; Ducharme FM
    Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of early effects of budesonide/formoterol maintenance and reliever therapy with fluticasone furoate/vilanterol for asthma patients requiring step-up from inhaled corticosteroid monotherapy.
    Hozawa S; Terada M; Haruta Y; Hozawa M
    Pulm Pharmacol Ther; 2016 Apr; 37():15-23. PubMed ID: 26850307
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Exhaled nitric oxide predicts loss of asthma control in children after inhaled corticosteroids withdrawal.
    Chang DV; Teper A; Balinotti J; Castro Simonelli C; Garcia-Bournissen F; Kofman C
    Pediatr Pulmonol; 2019 May; 54(5):537-543. PubMed ID: 30688035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Systematic review and economic analysis of the comparative effectiveness of different inhaled corticosteroids and their usage with long-acting beta2 agonists for the treatment of chronic asthma in children under the age of 12 years.
    Main C; Shepherd J; Anderson R; Rogers G; Thompson-Coon J; Liu Z; Hartwell D; Loveman E; Green C; Pitt M; Stein K; Harris P; Frampton GK; Smith M; Takeda A; Price A; Welch K; Somerville M
    Health Technol Assess; 2008 May; 12(20):1-174, iii-iv. PubMed ID: 18485272
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-Acting β-Agonist in Combination or Separate Inhaler as Step-Up Therapy for Children with Uncontrolled Asthma Receiving Inhaled Corticosteroids.
    Turner S; Richardson K; Murray C; Thomas M; Hillyer EV; Burden A; Price DB;
    J Allergy Clin Immunol Pract; 2017; 5(1):99-106.e3. PubMed ID: 27421902
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Impact of inhaled antiinflammatory therapy on hospitalization and emergency department visits for children with asthma.
    Adams RJ; Fuhlbrigge A; Finkelstein JA; Lozano P; Livingston JM; Weiss KB; Weiss ST
    Pediatrics; 2001 Apr; 107(4):706-11. PubMed ID: 11335748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of asthma control: the SERENA study.
    Corrado A; Renda T; Polese G; Rossi A;
    Respir Med; 2013 Nov; 107(11):1659-66. PubMed ID: 24045118
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tailored medication adherence incentives for high-risk children with asthma: a pilot study.
    Kenyon CC; Sundar KG; Gruschow SM; Quarshie WO; Feudtner C; Bryant-Stephens TC; Miller VA
    J Asthma; 2020 Dec; 57(12):1372-1378. PubMed ID: 31389724
    [No Abstract]   [Full Text] [Related]  

  • 49. Patterns of asthma medication use: early asthma therapy initiation and asthma outcomes at age 8.
    Koster ES; Wijga AH; Zuidgeest MG; Belitser SV; Raaijmakers JA; Koppelman GH; Postma DS; Brunekreef B; de Jongste JC; Maitland-van der Zee AH
    Pharmacoepidemiol Drug Saf; 2010 Oct; 19(10):991-9. PubMed ID: 20712022
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The influence of inhaled corticosteroid discontinuation in children with well-controlled asthma.
    Zheng S; Yu Q; Zeng X; Sun W; Sun Y; Li M
    Medicine (Baltimore); 2017 Sep; 96(35):e7848. PubMed ID: 28858095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The treatment of asthma in children: inhaled corticosteroids.
    Ricciardolo FL
    Pulm Pharmacol Ther; 2007; 20(5):473-82. PubMed ID: 16356743
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing differences in inhaled corticosteroid response by self-reported race-ethnicity and genetic ancestry among asthmatic subjects.
    Wells KE; Cajigal S; Peterson EL; Ahmedani BK; Kumar R; Lanfear DE; Burchard EG; Williams LK
    J Allergy Clin Immunol; 2016 May; 137(5):1364-1369.e2. PubMed ID: 27016472
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pediatric asthma controller therapy.
    Anselmo M
    Paediatr Drugs; 2011 Feb; 13(1):11-7. PubMed ID: 21162597
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inhaled Corticosteroid-Containing Treatment Escalation and Outcomes for Patients with Asthma in a U.S. Health Care Organization.
    Bengtson LGS; Yu Y; Wang W; Cao F; Hulbert EM; Wolbeck R; Elliott CA; Buikema AR
    J Manag Care Spec Pharm; 2017 Nov; 23(11):1149-1159. PubMed ID: 29083972
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alveolar nitric oxide and its role in pediatric asthma control assessment.
    Sardón O; Corcuera P; Aldasoro A; Korta J; Mintegui J; Emparanza JI; Pérez-Yarza EG
    BMC Pulm Med; 2014 Aug; 14():126. PubMed ID: 25090994
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children.
    Cates CJ; Karner C
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD007313. PubMed ID: 23633340
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The anti-inflammatory effects of inhaled corticosteroids versus anti-leukotrienes on the lymphocyte P-glycoprotein (PGP) expression in asthmatic children.
    Kopriva F; Dzubak P; Potesil J; Hajduch M
    J Asthma; 2009 May; 46(4):366-70. PubMed ID: 19484671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital discharge.
    Sadatsafavi M; Lynd LD; De Vera MA; Zafari Z; FitzGerald JM
    Respir Med; 2015 Mar; 109(3):320-8. PubMed ID: 25596136
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association of symptom control with changes in lung function, bronchial hyperresponsiveness, and exhaled nitric oxide after inhaled corticosteroid treatment in children with asthma.
    Park GM; Han HW; Kim JY; Lee E; Cho HJ; Yoon J; Hong SJ; Yang SI; Yang HJ; Yu J
    Allergol Int; 2016 Oct; 65(4):439-443. PubMed ID: 27160342
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Use of leukotriene receptor antagonists are associated with a similar risk of asthma exacerbations as inhaled corticosteroids.
    Wu AC; Li L; Fung V; Kharbanda EO; Larkin EK; Vollmer WM; Butler MG; Miroshnik I; Rusinak D; Davis RL; Hartert T; Weiss ST; Lieu TA
    J Allergy Clin Immunol Pract; 2014; 2(5):607-13. PubMed ID: 25213056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.